Drugs / autologous dendritic cells co-cultured with cytokine-induced killer cells
autologous dendritic cells co-cultured with cytokine-induced killer cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02504229 | Nov 2014 → Jul 2018 | gastric cancer | Beijing Biohealthcare Biotechnology Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous dendritic cells co-cultured with cytokine-induced killer cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02504229 ↗ |
| Modality | Cell therapy | “autologous dendritic cells co-cultured with cytokine-induced killer cells” NCT02504229 ↗ |